ResMed Research And Ddevelopement To Revenue Over Time
| RMD Stock | USD 242.51 3.27 1.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ResMed Performance and ResMed Correlation. ResMed |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.416 | Dividend Share 1.97 | Earnings Share 7.45 | Revenue Per Share 32.711 | Quarterly Revenue Growth 0.111 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Research And Ddevelopement To Revenue Analysis
Compare ResMed Inc and related stocks such as Teleflex Incorporated, West Pharmaceutical, and Alcon AG Research And Ddevelopement To Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TFX | 0.0155 | 0.0319 | 0.0363 | 0.0383 | 0.0332 | 0.0288 | 0.0314 | 0.0395 | 0.0434 | 0.0439 | 0.0472 | 0.0466 | 0.0551 | 0.0519 | 0.0302 |
| WST | 0.0158 | 0.0244 | 0.0262 | 0.0277 | 0.0262 | 0.0244 | 0.0244 | 0.0245 | 0.0235 | 0.0211 | 0.0218 | 0.0186 | 0.0203 | 0.0232 | 0.0179 |
| ALC | 0.0676 | 0.0676 | 0.0676 | 0.0676 | 0.0676 | 0.0676 | 0.0757 | 0.086 | 0.0821 | 0.0874 | 0.0985 | 0.1016 | 0.0805 | 0.0909 | 0.0685 |
| ICUI | 0.0428 | 0.0284 | 0.0335 | 0.0395 | 0.0593 | 0.046 | 0.0341 | 0.0397 | 0.0378 | 0.0384 | 0.0338 | 0.0361 | 0.0408 | 0.0378 | 0.0262 |
| COO | 0.0299 | 0.0358 | 0.0371 | 0.0386 | 0.0387 | 0.0333 | 0.0324 | 0.0335 | 0.0327 | 0.0384 | 0.0317 | 0.0333 | 0.0382 | 0.0398 | 0.0233 |
| BDX | 0.0643 | 0.0612 | 0.0613 | 0.0651 | 0.0615 | 0.0663 | 0.064 | 0.0629 | 0.0614 | 0.064 | 0.0661 | 0.0666 | 0.0639 | 0.059 | 0.0487 |
| HOLX | 0.0647 | 0.0819 | 0.0819 | 0.0819 | 0.0819 | 0.0819 | 0.0583 | 0.0583 | 0.0583 | 0.0583 | 0.0583 | 0.0583 | 0.0677 | 0.0677 | 0.073 |
| EMBC | 0.0559 | 0.0559 | 0.0559 | 0.0559 | 0.0559 | 0.0559 | 0.0559 | 0.0559 | 0.0559 | 0.0566 | 0.0541 | 0.0592 | 0.076 | 0.0702 | 0.0496 |
| BAX | 0.0368 | 0.0681 | 0.0815 | 0.0817 | 0.0852 | 0.0605 | 0.0637 | 0.058 | 0.0589 | 0.0524 | 0.0446 | 0.0418 | 0.04 | 0.045 | 0.0662 |
| MMSI | 0.0631 | 0.061 | 0.0705 | 0.0755 | 0.0719 | 0.0753 | 0.0749 | 0.0706 | 0.0674 | 0.066 | 0.0597 | 0.0663 | 0.0656 | 0.0658 | 0.0446 |
| STAA | 0.0664 | 0.1914 | 0.1914 | 0.1914 | 0.1914 | 0.1914 | 0.1953 | 0.1953 | 0.1953 | 0.1953 | 0.1953 | 0.1469 | 0.1377 | 0.1469 | 0.096 |
ResMed Inc and related stocks such as Teleflex Incorporated, West Pharmaceutical, and Alcon AG Research And Ddevelopement To Revenue description
The ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services.My Equities
My Current Equities and Potential Positions
| ResMed Inc | RMD |
| Classification | Obamacare Repeal |
| Location | California; U.S.A |
| Exchange | New York Stock Exchange |
USD 242.51
Check out ResMed Performance and ResMed Correlation. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
ResMed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.